Lewis b tetrasaccharide - unlocking the cell identification "password" for precision medicine

Lewis b tetrasaccharide is the core structure of a group of crucial glycocalyxes on the surface of human cells and is known as the "barcode" of cell identity. It is not only a key molecule in mediating intercellular communication, immune response and pathogen infection, but also a star compound emerging in modern biomedicine, especially in the fields of targeted drug development, anti-infection therapy and inflammation regulation.

Chemical Information

Chemical name: Lewis B tetrasaccharide

Common name: Lewis b tetrasaccharide

Chemical formula: C26H45NO19

Molecular weight: 675.63 g/mol

CAS number: 80081-06-7

Structural features

Lewis b tetrasaccharide is a fucosylated oligosaccharide antigen with an exquisite structure and specific functions:

Precise antigenic epitope: It is composed of specific monosaccharides such as fucose, galactose, and N-acetylglucosamine in precise order and linkage. This unique spatial conformation is the structural basis of its biorecognition function.

Key biological recognition site: The end of its structure serves as a specific binding target for a variety of proteins (such as lectins, bacterial adhesins), like a "keyhole" that only allows specific "key" molecules to bind to it, thereby mediating highly specific biological processes.

Main applications and advantages

1. Core tools for research on pathogen infection mechanisms and development of inhibitors

Cracking the code of infection: Pathogenic bacteria such as Helicobacter pylori specifically recognize and bind to the Lewis b antigen on the host gastric mucosal cells through the adhesin protein on their surface. This is the first step for them to colonize and cause gastritis, gastric ulcer and even gastric cancer. Lewis b tetrasaccharide is a key molecular tool for studying this process.

Develop new anti-infection therapies: Using Lewis b tetrasaccharide as a "bait" can competitively block the combination of pathogens and host cells, providing direct R&D targets and screening tools for the development of new anti-adhesion therapies (such as inhibitors and vaccines).

2. The cornerstone of drug development for immunomodulation and inflammatory diseases

Regulating immune cell trafficking: Adhesion molecules such as selectins recognize carbohydrate antigens including Lewis b and guide white blood cells to the site of inflammation. Intervening in this process can provide new drug design ideas for the treatment of autoimmune diseases (such as rheumatoid arthritis, inflammatory bowel disease) and allergic diseases.

Construct a targeted delivery system: Based on the specific binding of Lewis b tetrasaccharide and its receptor, a drug delivery system can be designed that can be accurately targeted to specific cell types (such as immune cells or tumor cells expressing corresponding lectins) to improve efficacy and reduce side effects.

3. Ideal probe for diagnostic reagent development and basic research

Highly sensitive diagnostic markers: In certain disease states, the levels of Lewis b-related antigens in body fluids change significantly, making them potential disease diagnostic biomarkers. Reliable standards for Lewis B tetrasaccharide development and calibration of relevant immunoassay kits.

Basic research on glycobiology: As an important component of the ABO blood group system and tissue blood group antigens, Lewis b tetrasaccharide plays a central role in cell recognition, signal transduction and developmental differentiation. Lewis B tetrasaccharides are ideal tools for exploring the biological functions of the sugar code.

Conclusion

Lewis b tetrasaccharide is not just a sugar chain molecule, it is a key bridge connecting microscopic recognition and macroscopic pathophysiological processes. From blocking pathogenic bacterial infections to regulating stubborn inflammation, from developing precise targeted drugs to innovative disease diagnosis solutions, its value is being continuously discovered.